15.72
price up icon1.09%   0.17
after-market Dopo l'orario di chiusura: 15.72
loading
Precedente Chiudi:
$15.55
Aprire:
$16.05
Volume 24 ore:
1.27M
Relative Volume:
0.97
Capitalizzazione di mercato:
$1.45B
Reddito:
$2.98B
Utile/perdita netta:
$-300.00M
Rapporto P/E:
-4.6235
EPS:
-3.4
Flusso di cassa netto:
$225.00M
1 W Prestazione:
+10.39%
1M Prestazione:
+38.62%
6M Prestazione:
+150.72%
1 anno Prestazione:
-22.45%
Intervallo 1D:
Value
$15.43
$16.33
Intervallo di 1 settimana:
Value
$14.02
$16.94
Portata 52W:
Value
$3.97
$20.86

Fortrea Holdings Inc Stock (FTRE) Company Profile

Name
Nome
Fortrea Holdings Inc
Name
Telefono
877-495-0816
Name
Indirizzo
8 MOORE DRIVE, DURHAM
Name
Dipendente
14,500
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-03
Name
Ultimi documenti SEC
Name
FTRE's Discussions on Twitter

Confronta FTRE con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
FTRE
Fortrea Holdings Inc
15.72 1.44B 2.98B -300.00M 225.00M -3.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.04 113.14B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
741.29 78.49B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
877.94 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
397.55 54.51B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
197.01 41.64B 447.02M -1.18B -906.14M -6.1812

Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-12-11 Aggiornamento Citigroup Neutral → Buy
2025-08-04 Aggiornamento Robert W. Baird Neutral → Outperform
2025-05-02 Iniziato Truist Hold
2025-04-10 Downgrade Barclays Equal Weight → Underweight
2024-12-11 Downgrade Citigroup Buy → Neutral
2024-12-06 Downgrade Robert W. Baird Outperform → Neutral
2024-09-25 Downgrade Jefferies Buy → Hold
2024-08-08 Downgrade Evercore ISI Outperform → In-line
2024-07-24 Ripresa Barclays Equal Weight
2024-06-06 Iniziato Goldman Neutral
2024-05-29 Iniziato TD Cowen Hold
2024-05-28 Iniziato Mizuho Neutral
2024-03-22 Iniziato Robert W. Baird Neutral
2024-03-06 Iniziato Deutsche Bank Hold
2024-01-05 Iniziato William Blair Mkt Perform
2024-01-04 Iniziato Jefferies Buy
2023-12-11 Aggiornamento Citigroup Neutral → Buy
2023-12-01 Aggiornamento Evercore ISI In-line → Outperform
2023-11-14 Aggiornamento Barclays Equal Weight → Overweight
2023-10-19 Iniziato Citigroup Neutral
2023-09-14 Iniziato Evercore ISI In-line
2023-08-16 Iniziato Barclays Equal Weight
2023-08-07 Iniziato BofA Securities Underperform
Mostra tutto

Fortrea Holdings Inc Borsa (FTRE) Ultime notizie

pulisher
Dec 13, 2025

Liquidity Mapping Around (FTRE) Price Events - news.stocktradersdaily.com

Dec 13, 2025
pulisher
Dec 13, 2025

Beck Mack & Oliver LLC Sells 916,179 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat

Dec 13, 2025
pulisher
Dec 12, 2025

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. ... - Bakersfield.com

Dec 12, 2025
pulisher
Dec 12, 2025

Notice to Long-Term Shareholders of Cytokinetics, Inc. - GlobeNewswire

Dec 12, 2025
pulisher
Dec 12, 2025

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire Inc.

Dec 12, 2025
pulisher
Dec 12, 2025

Fortrea (NASDAQ:FTRE) Shares Gap UpShould You Buy? - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

1,029,700 Shares in Fortrea Holdings Inc. $FTRE Acquired by Bank of Nova Scotia - MarketBeat

Dec 12, 2025
pulisher
Dec 11, 2025

Why Fortrea (FTRE) Stock Is Up Today - Finviz

Dec 11, 2025
pulisher
Dec 11, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Dec 11, 2025
pulisher
Dec 11, 2025

Important Notice to Long-Term Shareholders of Alexandria - GlobeNewswire

Dec 11, 2025
pulisher
Dec 11, 2025

Citigroup Upgrades Fortrea Holdings to Buy From Neutral - marketscreener.com

Dec 11, 2025
pulisher
Dec 10, 2025

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Enidnews.com

Dec 10, 2025
pulisher
Dec 10, 2025

Fortrea (NASDAQ:FTRE) Shares Up 5.5%Still a Buy? - MarketBeat

Dec 10, 2025
pulisher
Dec 09, 2025

Fortrea Holdings, Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Dec 09, 2025
pulisher
Dec 09, 2025

Kennedy Capital Management LLC Sells 111,459 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat

Dec 09, 2025
pulisher
Dec 08, 2025

Attention Long-Term Shareholders of Cytokinetics, Inc. - GlobeNewswire

Dec 08, 2025
pulisher
Dec 07, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FTRE) And Encourages Investors to Connect - ACCESS Newswire

Dec 07, 2025
pulisher
Dec 07, 2025

Fortrea Holdings Inc. (NASDAQ:FTRE) Surges 27% Yet Its Low P/S Is No Reason For Excitement - simplywall.st

Dec 07, 2025
pulisher
Dec 06, 2025

Fortrea Holdings (NASDAQ:FTRE) NASDAQ Index Fund Biopharma Power - Kalkine Media

Dec 06, 2025
pulisher
Dec 05, 2025

Fortrea (NASDAQ:FTRE) Stock Price Down 5.7%Time to Sell? - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

Fortrea, SCTbio announce strategic collaboration agreement - MSN

Dec 05, 2025
pulisher
Dec 05, 2025

How Fortrea Holdings Inc. (K67) stock compares with market leadersMarket Sentiment Report & Technical Pattern Alert System - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

What dividend safety score for Fortrea Holdings Inc. stockPortfolio Return Report & Low Risk High Win Rate Picks - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Fortrea Holdings Inc. (NASDAQ:FTRE) Receives Average Recommendation of "Hold" from Analysts - MarketBeat

Dec 05, 2025
pulisher
Dec 04, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings, Inc. (FTRE) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Dec 04, 2025
pulisher
Dec 04, 2025

Will Fortrea Holdings Inc. (K67) stock outperform global peersJuly 2025 Decliners & Reliable Volume Spike Trade Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Fortrea (NASDAQ:FTRE) Shares Up 10.1%Time to Buy? - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

SCTbio and Fortrea forge strategic collaboration to accelerate cell and gene therapy development and delivery - marketscreener.com

Dec 04, 2025
pulisher
Dec 04, 2025

Fortrea, SCTbio Collaborate Over Cell, Gene Therapy Development, Delivery - marketscreener.com

Dec 04, 2025
pulisher
Dec 04, 2025

SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery - The Globe and Mail

Dec 04, 2025
pulisher
Dec 04, 2025

Capital Fund Management S.A. Grows Stake in Fortrea Holdings Inc. $FTRE - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

Geode Capital Management LLC Increases Stake in Fortrea Holdings Inc. $FTRE - MarketBeat

Dec 04, 2025
pulisher
Dec 03, 2025

Fortrea (FTRE) Valuation Check After Investigation into Alleged Overstated Revenue, Cost Savings, and 2025 EBITDA Targets - Yahoo Finance

Dec 03, 2025
pulisher
Dec 03, 2025

Improved Revenues Required Before Fortrea Holdings Inc. (NASDAQ:FTRE) Stock's 26% Jump Looks Justified - 富途牛牛

Dec 03, 2025
pulisher
Dec 03, 2025

Brandes Investment Partners LP Acquires 94,448 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Is Fortrea Holdings Inc. stock trading at a premium valuationJuly 2025 Gainers & Weekly Return Optimization Alerts - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Fortrea (FTRE) Valuation Check as Legal Probe Questions Revenue Recognition and 2025 EBITDA Targets - simplywall.st

Dec 02, 2025
pulisher
Dec 02, 2025

Levi & Korsinsky Notifies Fortrea Holdings Inc. (FTRE) Investors - The National Law Review

Dec 02, 2025
pulisher
Dec 02, 2025

Why (FTRE) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com

Dec 02, 2025
pulisher
Dec 02, 2025

Transcript : Fortrea Holdings Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 01 - marketscreener.com

Dec 02, 2025
pulisher
Dec 02, 2025

Important Notice to Long-Term Shareholders of Cytokinetics, - GlobeNewswire

Dec 02, 2025
pulisher
Dec 02, 2025

Will Fortrea Holdings Inc. (K67) stock benefit from sector leadership2025 Big Picture & Low Risk Entry Point Tips - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

SG Americas Securities LLC Reduces Position in Fortrea Holdings Inc. $FTRE - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

How strong is Fortrea Holdings Inc. stock revenue growthTrade Exit Summary & Real-Time Buy Zone Alerts - Newser

Dec 02, 2025
pulisher
Nov 30, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdi - The National Law Review

Nov 30, 2025
pulisher
Nov 30, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FTRE) And Encourages Stockholders to Connect - ACCESS Newswire

Nov 30, 2025
pulisher
Nov 29, 2025

Is Fortrea Holdings Inc. stock a safe haven assetCEO Change & Detailed Earnings Play Strategies - BỘ NỘI VỤ

Nov 29, 2025
pulisher
Nov 29, 2025

Envestnet Asset Management Inc. Sells 69,467 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat

Nov 29, 2025
pulisher
Nov 27, 2025

Fortrea Holdings, Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Nov 27, 2025
pulisher
Nov 27, 2025

Can Fortrea Holdings Inc. stock maintain growth trajectory2025 Fundamental Recap & AI Enhanced Trading Signals - moha.gov.vn

Nov 27, 2025
pulisher
Nov 26, 2025

Fortrea (NASDAQ:FTRE) Stock Price Up 7.4%What's Next? - MarketBeat

Nov 26, 2025

Fortrea Holdings Inc Azioni (FTRE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Fortrea Holdings Inc Azioni (FTRE) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Parks Robert
Chief Accounting Officer
Sep 16 '25
Sale
9.95
7,338
73,013
19,046
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Capitalizzazione:     |  Volume (24 ore):